USPTO trademark

DIFCYSEV

RegisteredUSPTOWord markClass 5

"DIFCYSEV" is a word mark owned by H. Lundbeck A/S, filed at the USPTO on June 21, 2021. It is registered and covers class 5 (Pharmaceuticals).

View H. Lundbeck A/S portfolioGet this data via the API
Official USPTO record
DIFCYSEV trademark as filed
As filed with the USPTO
Status
Registered
Since August 23, 2022
Filed
June 21, 2021
Registered
August 23, 2022
Expires
Not recorded
Application no.
90786273
Registration no.
6824541
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns DIFCYSEV

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

H. Lundbeck A/S

Valby, Denmark

1,749 trademarks in the portfolioView company

Representative

Claudia A. Smith

White & Case LLP

Goods and services

What the mark covers

The products and services DIFCYSEV is filed for, grouped by Nice class.

  • Pharmaceuticals and medical preparations and substances; vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, pain, alcoholism and dependency; preparations, substances, reagents and agents for diagnostic and medical purposes

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

8 earlier steps on the official record.

FAQ

About DIFCYSEV

Who owns the trademark "DIFCYSEV"?

The USPTO trademark "DIFCYSEV" (application 90786273) is owned by H. Lundbeck A/S.

What is the status of "DIFCYSEV"?

Its status at the USPTO is: registered.

When was "DIFCYSEV" registered?

It was registered on August 23, 2022.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DIFCYSEV and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2d72-f060-713f-b273-ed3ad0e998f3
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2d72-f060-713f-b273-ed3ad0e998f3",
  "object": "trademark",
  "mark_text": "DIFCYSEV",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "90786273",
  "filing_date": "2021-06-21",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "H. Lundbeck A/S",
      "entity_id": "ent_019eb6fd-c6b8-7323-bcf8-455bb92dfb3d"
    }
  ]
}